Nonalcoholic Fatty Liver Disease in 2020.
作者信息
Maher Jacquelyn J, Schattenberg Jörn M
机构信息
Department of Medicine and Liver Center, University of California, San Francisco, San Francisco, California.
Metabolic Liver Research Program, I. Department of Medicine, University Medical Center, Mainz, Germany.
出版信息
Gastroenterology. 2020 May;158(7):1849-1850. doi: 10.1053/j.gastro.2020.04.013. Epub 2020 Apr 14.
Abstract
摘要
相似文献
1
Nonalcoholic Fatty Liver Disease in 2020.2020年的非酒精性脂肪性肝病
Gastroenterology. 2020 May;158(7):1849-1850. doi: 10.1053/j.gastro.2020.04.013. Epub 2020 Apr 14.
2
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.非酒精性脂肪性肝病：从非酒精性脂肪性肝病到非酒精性脂肪性肝炎的进展中的基本发病机制。
Transplantation. 2019 Jan;103(1):e1-e13. doi: 10.1097/TP.0000000000002480.
3
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?非酒精性脂肪性肝病：调节肠道微生物群以改善严重程度？
Gastroenterology. 2020 May;158(7):1881-1898. doi: 10.1053/j.gastro.2020.01.049. Epub 2020 Feb 8.
4
The Gut Microbiota and Nonalcoholic Fatty Liver Disease.肠道微生物群与非酒精性脂肪性肝病
Semin Liver Dis. 2015 Aug;35(3):262-9. doi: 10.1055/s-0035-1562946. Epub 2015 Sep 17.
5
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.脂肪组织-肝脏对话在全身代谢调控中的作用：非酒精性脂肪性肝病的启示。
Gastroenterology. 2020 May;158(7):1899-1912. doi: 10.1053/j.gastro.2019.12.054. Epub 2020 Feb 13.
6
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?益生菌在非酒精性脂肪性肝病中的作用：肠道微生物组是否重要？
Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837.
7
[Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target].[吞噬疗法杀死参与营养性肝病的肠道细菌：一个新的治疗靶点]
Med Sci (Paris). 2020 Apr;36(4):310-312. doi: 10.1051/medsci/2020052. Epub 2020 May 1.
8
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?酒精性和非酒精性脂肪性肝病中的肝细胞癌是同一种疾病吗？
Gastroenterology. 2016 Jun;150(8):1710-7. doi: 10.1053/j.gastro.2016.01.006. Epub 2016 Jan 16.
9
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: II. Complexity in pathogenesis of nonalcoholic fatty liver disease].[非酒精性脂肪性肝病的临床重要性。主题：二、非酒精性脂肪性肝病发病机制的复杂性]
Nihon Naika Gakkai Zasshi. 2016 Jan 10;105(1):15-24. doi: 10.2169/naika.105.15.
10
Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization.全身性 SIRT1 活性的消融通过影响肝肠系膜脂肪组织脂肪酸动员促进非酒精性脂肪性肝病。
Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2783-2790. doi: 10.1016/j.bbadis.2017.08.004. Epub 2017 Aug 5.
引用本文的文献
1
Dietary Inflammatory index and its association with fatty liver disease: a study in obese and non-obese populations.饮食炎症指数及其与脂肪肝疾病的关联：一项针对肥胖和非肥胖人群的研究。
BMC Gastroenterol. 2025 Feb 21;25(1):102. doi: 10.1186/s12876-024-03585-1.
2
Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease.整合空间代谢组学和转录组学解析水飞蓟宾和去甲基水飞蓟宾对非酒精性脂肪性肝病的肝保护机制。
J Pharm Anal. 2024 Apr;14(4):100910. doi: 10.1016/j.jpha.2023.11.017. Epub 2023 Nov 29.
3
A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials.重新审视非酒精性脂肪性肝病的药物和潜在治疗靶点：从临床试验中学习。
J Endocrinol Invest. 2024 Apr;47(4):761-776. doi: 10.1007/s40618-023-02216-y. Epub 2023 Oct 15.
4
Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis.幽门螺杆菌感染与非酒精性脂肪性肝病在亚洲人群和非亚洲人群中的相关性：系统评价和荟萃分析。
Front Public Health. 2022 Dec 8;10:1062942. doi: 10.3389/fpubh.2022.1062942. eCollection 2022.
5
The Gut Microbiome and Nonalcoholic Steatohepatitis.肠道微生物群与非酒精性脂肪性肝炎
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):166-168.
6
Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults.非酒精性脂肪性肝病与中老年成年人的纵向认知变化
Front Med (Lausanne). 2022 Jan 17;8:738835. doi: 10.3389/fmed.2021.738835. eCollection 2021.
7
Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease.超声技术在肝细胞癌和非酒精性脂肪性肝病评估中的表现及人工智能的潜力
Cancers (Basel). 2021 Feb 14;13(4):790. doi: 10.3390/cancers13040790.
Zotero 插件